<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1309211043
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        IMIGRAN
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SUMATRIPTAN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        6
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        100.85
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DELPHARM POZNAN SPOLKA AKCYJNA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DELPHARM POZNAN SPOLKA AKCYJNA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02CC01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>IMIGRAN contains sumatriptan, which belongs to a group of medicines called triptans <em>(also known as 5-HT1 receptor agonists).</em></p><p><strong>IMIGRAN is used to treat migraine.</strong></p><p>Migraine symptoms may be caused by the temporary widening of blood vessels in the head. IMIGRAN is believed to reduce the widening of these blood vessels. This in turn helps to take away the headache and relieve other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and sensitivity to light and sound</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Don&rsquo;t take IMIGRAN</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With any of the following anti-depressants:</p><p>o&nbsp; MAOIs (monoamine oxidase inhibitors) or if you have taken an MAOI in the last 2 weeks</p><p>o&nbsp; SSRIs (selective serotonin reuptake inhibitors) including citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline</p><p>o&nbsp; SNRIs (serotonin noradrenaline reuptake inhibitors) including venlafaxine and duloxetine</p><p>o&nbsp; &nbsp;&nbsp; For children under 18 years of age.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you&rsquo;re allergic</strong> <em>(hypersensitive)</em> to sumatriptan or any of the other ingredients (listed in Section 6).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you have a heart problem </strong>such as heart failure or chest pains (<em>angina</em>), or have already had a heart attack.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you have circulation problems in your legs </strong>that cause cramp-like pains when you walk (<em>peripheral vascular disease</em>).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you have had a stroke or </strong>a mini-stroke (<em>also called a transient ischaemic attack or TIA</em>).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you have high blood pressure.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you have liver disease, </strong>check with your doctor. If your liver problems are severe then IMIGRAN is not suitable for you.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>with other migraine medicines, </strong>including those which contain ergotamine, or similar medicines such as methysergide.</p><p><strong>&nbsp;</strong></p><p>&egrave; If you think any of these apply to you, <strong>don&rsquo;t take IMIGRAN</strong> until you have checked with your doctor.</p><p>Take special care with IMIGRAN</p><p><strong>IMIGRAN is not recommended</strong> for people aged over 65, or for children under the age of 18.</p><p>Your doctor needs to know before you take IMIGRAN <strong>if you have extra risk factors for heart disease:</strong></p><p>&Yuml;&nbsp; <strong>if you are a man over 40, or</strong></p><p>&Yuml;&nbsp; <strong>if you are a woman who has been through the menopause</strong></p><p>&Yuml;&nbsp; <strong>if you smoke or are overweight</strong></p><p>&Yuml;&nbsp; <strong>if you have diabetes or high cholesterol</strong></p><p>&Yuml;&nbsp; <strong>if you have a strong family history of heart disease.</strong></p><p>If any of the points in the list applies to you, it could mean you have a greater risk of developing heart disease &ndash; so:</p><p>&egrave; <strong>Tell your doctor so that your heart function can be checked </strong>before IMIGRAN is prescribed for you.</p><p>In very rare cases, people have developed serious heart conditions after taking IMIGRAN, even though they had no signs of heart disease before.</p><p>Before you take IMIGRAN your doctor needs to know</p><p>If you have had high blood pressure</p><p>IMIGRAN may not be suitable for you:</p><p>&egrave; <strong>Tell your doctor or pharmacist before using IMIGRAN.</strong></p><p><strong>If you have kidney or liver disease</strong></p><p>&egrave; <strong>Tell your doctor or pharmacist before using IMIGRAN.</strong></p><p>If you have a history of seizures <em>(fits)</em></p><p>or if you have other conditions which might make it more likely that you&rsquo;ll have a fit &ndash; for example, a head injury or alcoholism:</p><p>&egrave; <strong>Tell your doctor so that you can be supervised more closely.</strong></p><p>If you are allergic to antibiotics called sulphonamides</p><p>If so, you may also be allergic to IMIGRAN. If you know you are allergic to an antibiotic but you are not sure whether it is a sulphonamide:</p><p>&egrave; <strong>Tell your doctor or pharmacist before using IMIGRAN.</strong></p><p>While you are taking IMIGRAN your doctor needs to know</p><p>If you feel pain or tightness in your chest after you use IMIGRAN</p><p>These effects may be intense but they usually pass quickly. If they don&rsquo;t pass quickly, or if they become severe:</p><p>&egrave; <strong>Get medical help immediately. </strong>See &lsquo;Possible side effects&rsquo; in section 4.</p><p>If you take IMIGRAN frequently</p><p>Taking IMIGRAN too often may make your headaches worse</p><p>&egrave; <strong>Tell your doctor if this applies to you. </strong>You may need to stop taking IMIGRAN.<strong> </strong></p><p><strong>Other medicines and IMIGRAN</strong></p><p><strong>Tell your doctor or pharmacist</strong> if you&rsquo;re taking, have recently taken or might take any other medicines. This includes any herbal products or medicines you&rsquo;ve bought without a prescription. Some medicines must not be taken with Imigran and others may cause adverse effects if they&rsquo;re taken with Imigran. You must tell your doctor if you are taking: &nbsp;&nbsp;</p><p>&egrave; ergotamine also used to treat migraine, or similar medicines such as methysergide (see section 2 Don&rsquo;t use Imigran). Don&rsquo;t use Imigran at the same time as these medicines. Stop taking these medicines at least 24 hours before using Imigran. Don&rsquo;t take any medicines which contain ergotamine or compounds similar to ergotamine again for at least 6 hours after using Imigran.</p><p>&egrave; other triptans/5-HT1 receptor agonists (such as naratriptan, rizatriptan, zolmitriptan), also used to treat migraine, (see section 2 Don&rsquo;t use Imigran). Don&rsquo;t use Imigran at the same time as these medicines. Stop taking these medicines at least 24 hours before using Imigran. Don&rsquo;t take another triptan/5-HT1 receptor agonist again for at least 24 hours after using Imigran.</p><p>&egrave; MAOIs used to treat depression. Don&rsquo;t use Imigran if you have taken these in the last 2 weeks</p><p>&egrave; &nbsp;SSRIs and SNRIs used to treat depression. Using Imigran with these medicines can cause serotonin syndrome (a collection of symptoms which can include restlessness, confusion, sweating, hallucinations, increased reflexes, muscle spasms, shivering, increased heartbeat and shaking). Tell your doctor immediately if you are affected in this way.</p><p>St John&rsquo;s Wort (Hypericum perforatum). Taking herbal remedies that contain St John&rsquo;s Wort together with Imigran may make side effects more likely</p><p>&nbsp;</p><p><strong>Contact your doctor immediately </strong>if you get any of these symptoms<strong>.</strong></p><p><strong>Pregnancy and breast-feeding</strong></p><p><strong>IMIGRAN is not recommended for use during pregnancy</strong>. If you are<strong> pregnant</strong> or<strong> think you could be, </strong>or if you are <strong>planning to become pregnant, don&rsquo;t take IMIGRAN</strong> without checking with your doctor. <strong>Your doctor</strong> will weigh up the benefit to you against the risk to your baby of taking IMIGRAN while you&rsquo;re pregnant.<strong> </strong></p><p>The ingredients in IMIGRAN can pass into breast milk. <strong>Don&rsquo;t breast-feed your baby for 12 hours after taking IMIGRAN.</strong> If you express any breast milk during this time, discard the milk and don&rsquo;t give it to your baby.<strong> </strong></p><p><strong>Driving and using machines</strong></p><p>The symptoms of the migraine or IMIGRAN may make you drowsy.</p><p><strong>Don&rsquo;t drive or use machines unless you are feeling well.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take IMIGRAN exactly as your doctor has told you. Check with your doctor or pharmacist if you&rsquo;re not sure.</p><p>How much to take</p><p><strong>The usual dose for adults aged 18 to 65 </strong>is a single IMIGRAN 50mg tablet. Some patients may require 100mg.</p><p>How to take IMIGRAN Tablets</p><p>Swallow the tablet whole with some water.</p><p>When to take IMIGRAN Tablets</p><p><strong>Take IMIGRAN as soon as your migraine begins.</strong> Although IMIGRAN may also be taken at any time after the headache has started.</p><p><strong>Don&rsquo;t take IMIGRAN to try to prevent an attack</strong>.</p><p>If your symptoms start to come back</p><p>You may take a second IMIGRAN tablet no sooner than <strong>two&nbsp;hours </strong>after the first<strong>. </strong></p><p>If the first tablet has no effect</p><p>Don&rsquo;t take a second tablet or any other IMIGRAN preparations for the same attack. If IMIGRAN doesn&rsquo;t give you any relief:</p><p>&nbsp;</p><p>Don&rsquo;t take more than six 50 mg tablets or three 100 mg tablets (300 mg in total) in any 24 hours.</p><p>&egrave;&nbsp;&nbsp;&nbsp; <strong>Ask your doctor or pharmacist for advice</strong>.</p><p>If you take too much IMIGRAN</p><p>Taking too much IMIGRAN could make you ill. If you take more than the recommended dose:</p><p>If you have taken more than 300 mg in 24 hours:</p><p>&nbsp;</p><p>&egrave; <strong>Contact your doctor or pharmacist as soon as possible for advice. </strong>If possible, show them the IMIGRAN pack.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, IMIGRAN can cause side effects, but not everybody gets them.</p><p>Allergic reactions: These are very rare in people taking IMIGRAN. Signs include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; raised and itchy rash <em>(hives)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling sometimes of the face or mouth <em>(angioedema)</em> causing difficulty in breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse.</p><p>&egrave; <strong>Contact a doctor immediately</strong> if you get any of these symptoms<strong>. Stop taking IMIGRAN.</strong></p><p>Common side effects</p><p>These may affect <strong>up to 1 in 10</strong> people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness, feeling weak, or getting hot flushes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; temporary increase in blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick (nausea) or being sick (vomiting), although this may be due to the migraine itself</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness or drowsiness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; aching muscles</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unusual sensations including numbness, tingling and feeling hot/cold</p><p>pain, heaviness or pressure in any part of the body including the chest and throat.</p><p>Very rare side effects</p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain in the lower left side of the stomach and bloody diarrhoea <em>(ischaemic colitis)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pale, blue-tinged skin and/or pain in your fingers, toes, ears, nose or jaw in response to cold or stress <em>(Raynaud&rsquo;s phenomenon)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seizures (fits), tremors, muscle spasm, neck stiffness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling faint (blood pressure may go down)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart problems</p><p>where your heart beat may go faster <em>(tachycardia)</em>, slower <em>(bradycardia)</em> or change rhythm <em>(cardiac arrhythmias)</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart attack</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reaction</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; visual disturbances such as flickering, reduced vision, double vision, loss of vision, and in some cases even permanent defects (although these may be due to the migraine attack itself).</p><p>Very rare side effects that may show up in your blood tests:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; minor changes in liver function.</p><p>If you get side effects</p><p>&egrave; <strong>Tell your doctor or pharmacist</strong> if any of the side effects listed becomes <strong>severe or troublesome</strong>, or if you notice any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li><strong>Keep out of the reach and sight of children.</strong></li><li>Do not use IMIGRAN tablet after the expiry date which is stated on the pack after &lsquo;Exp&rsquo;.</li><li>Do not Store IMIGRAN tablet at above 30&deg;C.</li><li>If your doctor tells you to stop taking IMIGRAN tablet, it is important to return any remnants which are left over to your pharmacist.</li></ul><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What IMIGRAN contains</p><p>Active ingredients:</p><p><strong><em>IMIGRAN</em></strong><strong><em> Tablet 50 </em></strong>containing 50 mg of sumatriptan base as the succinate salt.</p><p><strong><em>IMIGRAN</em></strong><strong><em> Tablet 100 </em></strong>containing 100 mg of sumatriptan base as the succinate salt.</p><p>Non-active ingredients:</p><p><strong><em>IMIGRAN</em></strong><strong><em> Tablet 50: </em></strong>Lactose (monohydrate), Lactose (anhydrous), Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Purified water</p><p><strong><em>IMIGRAN Tablet 100:</em></strong><strong><em> </em></strong>Lactose (monohydrate), Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What IMIGRAN tablet looks like and contents of the pack
IMIGRAN Tablet 50
Pink, film coated, capsule-shaped biconvex tablets engraved GX ES3 on one face and plain on the other face or 50 on one face and plain on the other face.
Packed in individual pockets in double foil blister packs and placed in a cardboard carton.
IMIGRAN Tablet 100
White to off-white, film coated, capsule-shaped  biconvex  tablets engraved GX ET2 on one face and plain on the other face or 100 on one face and plain on the other face.
Packed in individual pockets in double foil blister packs and placed in a cardboard carton.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by:</strong></p><p>Delpharm Poznań Sp&oacute;łka Akcyjna, ul. Grunwaldzka 189, 60-322 Poznan, Poland</p><p><strong>Packed by:</strong></p><p>Glaxo Saudi Arabia Ltd.*, Jeddah, KSA.</p><p><strong>Marketing Authorisation Holder </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA.</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia.</p><p>*member of GlaxoSmithKline group of companies.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: GDS24
Date of issue: 10 April 2023


            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي إيميجران على سوماتريـﭙـتان، وهو ينتمي إلى مجموعة من الأدوية تدعى مركبات التريـﭙـتان. (أيضاً يعرف بناهضات مستقبلات 5-إتش تي 1)</p><p><strong>إيميجران يستعمل لعلاج الصداع النصفي.</strong></p><p>أعراض الصداع النصفي قد تكون ناتجة عن توسع مؤقت بالأوعية الدموية في الرأس. من المعتقد أن إيميجران يقلل توسع هذه الأوعية الدموية. وهذا بدوره يساعد على التخلص من الصداع وتخفيف الأعراض الأخرى لنوبة الصداع النصفي، مثل الشعور أو الإصابة بغثيان (غثيان أو قيء) والحساسية للضوء والصوت.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا يجوز تناول إيميجران:</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>مع أي من مضادات الاكتئاب التالية:</strong></p><p><strong><em>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>مضادات للاكتئاب</strong> تدعى مثبطات أكسيداز أحادي الأمين MAOIs</p><p><em>(</em><em><u>m</u></em><em>onaine <u>o</u>xidase <u>i</u>nhibitors</em><em>)، </em>أو إذا تناولت مثل هذه الأدوية خلال الأسبوعين السابقين.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مثبطات</strong><strong> </strong><strong>امتصاص</strong><strong> </strong><strong>السيروتونين</strong><strong> </strong><strong>الانتقائية</strong><strong> </strong><strong>(SSRI)</strong><strong> </strong>المتضمنة سيتالوبرام، فلوكسيتين، فلوفوكسامين، باروكسيتين وسيرترالين.</p><p><strong>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>مثبطات</strong><strong> </strong><strong>امتصاص</strong><strong> </strong><strong>السيروتونين</strong><strong> </strong><strong>النورادرينالين</strong><strong> </strong><strong>(SNRI)</strong><strong> </strong>المتضمنة فينلافاكسين وديولوكسيتين.</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>للأطفال الذين تقل أعمارهم عن 18 سنة.</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت مصاباً بحساسية</strong> <em>(مفرط الحساسية)</em> للسوماتريـﭙـتان أو لأي من المكونات الأخرى (المدرجة بالفقرة 6).</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت تعاني من مشكلة بالقلب</strong> مثل فشل القلب أو آلام بالصدر <em>(ذبحة صدرية)،</em> أو إذا أصبت سابقاً بنوبة قلبية.</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت تعاني من مشاكل بالدورة الدموية في الساقين</strong> تسفر عن آلام شبيهة بالتقلصات عند المشي <em>(مرض وعائي طرفي).</em></p><p><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>إذا أصبت سابقاً بسكتة دماغية</strong> أو بسكتة دماغية مصغرة <em>(تدعى أيضاً نوبة نقص تروية عابرة أو </em><em>TIA</em><em>).</em></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت مصاباً بارتفاع ضغط الدم.</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت مصاباً بمرض كبدي، </strong>يرجى الرجوع إلى الطبيب. إذا كانت تعاني من مشاكل خطيرة بالكبد، حينها لا يكون إيميجران مناسباً لك.</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>مع أدوية أخرى لعلاج الصداع النصفي،</strong> بما في ذلك تلك التي تحتوي على الإرجوتامين، أو الأدوية المشابهة مثل ميثايسيرجايد.</p><p><strong>&nbsp;</strong></p><p>&not; إذا ظننت أن أي من ذلك ينطبق عليك، <strong>لا يجوز تناول إيميجران </strong>إلا بعد الرجوع إلى الطبيب.</p><p><strong>يجب توخي الحذر الشديد عند تناول </strong><strong>إيميجران</strong></p><p><strong>إيميجران لا يوصى بتناوله</strong> للأفراد الذين يزيد سنهم عن 65 عاماً، أو للأطفال دون سن 18 عاماً.</p><p>قبل تناول إيميجران يحتاج الطبيب إلى أن يعرف ما <strong>إذا كانت لديك عوامل إضافية لخطر الإصابة بمرض قلبي:</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت رجلاً وسنك يزيد عن 40 عاماً، أو</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت سيدة تجاوزت سن اليأس</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت تدخن أو تعاني من زيادة الوزن</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كنت مصاباً بداء السكري أو ارتفاع مستوى الكوليسترول</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إذا كانت لديك سوابق عائلية قوية للإصابة بمرض قلبي.</strong></p><p>إذا كانت أي من النقاط المدرجة بالقائمة تنطبق عليك، ذلك قد يعني أنك أكثر عرضة للإصابة بمرض قلبي - لذلك:</p><p>&not; <strong>يجب إبلاغ الطبيب حتى يقوم بإجراء فحص لوظائف القلب لديك</strong> قبل وصف إيميجران لك.</p><p>في حالات نادرة جداً، أصيب أفراد بحالات قلبية خطيرة بعد تناول إيميجران، رغم عدم وجود أية علامات لديهم للإصابة بمرض قلبي سابقاً.</p><p><strong>قبل تناول إيميجران، يجب أن يكون الطبيب على علم بالتالي</strong></p><p><strong>إذا كانت لديك سوابق للإصابة بضغط الدم المرتفع</strong></p><p>لا يكون إيميجران مناسباً لك:</p><p><strong>&not;</strong><strong> يجب إبلاغ الطبيب أو الصيدلي قبل استخدام إيميجران.</strong></p><p><strong>إذا كانت لديك مرض بالكى أو الكبد</strong></p><p><strong>&not;</strong><strong> يجب إبلاغ الطبيب أو الصيدلي قبل استخدام إيميجران.</strong></p><p><strong>إذا كانت لديك سوابق للإصابة بنوبات صرع</strong> <em>(نوبات)</em></p><p>أو إذا كنت مصاباً بحالات أخرى قد تجعلك أكثر عرضة للإصابة بنوبة - على سبيل المثال، إصابة بالرأس أو إدمان الكحوليات:</p><p><strong>&not;</strong><strong> يجب إبلاغ الطبيب حتى يتمكن من الإشراف عليك عن كثب أكثر.</strong></p><p><strong>إذا كنت مصاباً بحساسية لمضادات حيوية تدعى مركبات السلفوناميد</strong></p><p>في هذه الحالة، قد تكون مفرط الحساسية لإيميجران أيضاً. إذا كنت تعلم أنك مفرط الحساسية لمضاد حيوي لكن لست متأكداً إذا كان أحد مركبات السلفوناميد:</p><p><strong>&not;</strong><strong> يجب إبلاغ الطبيب أو الصيدلي قبل تناول إيميجران.</strong></p><p><strong>أثناء تناول إيميجران، يجب أن يكون الطبيب على علم بالتالي</strong></p><p><strong>إذا كنت تعاني من ألم أو ضيق بالصدر بعد تناول إيميجران</strong></p><p>هذه التأثيرات قد تكون شديدة إلا أنها تزول بسرعة عادةً. إذا لم تزول بسرعة، أو إذا أصبحت أكثر شدة:</p><p><strong>&not;</strong><strong> يجب الحصول على مساعدة طبية على الفور.</strong> انظر &quot;الآثار الجانبية المحتملة&quot; في الفقرة 4.</p><p><strong>إذا كنت تتناول إيميجران على نحو متكرر</strong></p><p>تناول إيميجران بكثرة قد يزيد من حدة نوبات الصداع لديك.</p><p><strong>&not;</strong><strong> يجب إبلاغ الطبيب إذا كان ذلك ينطبق عليك. </strong>قد تحتاج إلى وقف تناول إيميجران.</p><p><strong>الأدوية الأخرى و إيميجران</strong></p><p><strong>يجب إبلاغ الطبيب أو الصيدلي إذا كنت تتناول أية أدوية أخرى،</strong> أو إذا تناولت أية أدوية مؤخراً، أو إذا بدأت بتناول أدوية جديدة. وذلك يشمل الأدوية التي تشترى بدون وصفة طبية.</p><p>بعض الأدوية لا يجوز تناولها بمصاحبة إيميجران وبعض الأدوية الأخرى قد تسفر عن تأثيرات غير مستحبة في حالة تناولها بمصاحبة إيميجران. ومن جملتها:</p><p><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإرجوتامين</strong> الذي يُستخدم أيضًا لعلاج الصداع النصفي، أو أي أدوية مشابهة مثل الميثايسيرجايد (انظر الفقرة ٢). لا تستخدم إيميجران في نفس الوقت الذي تتناول فيه هذه الأدوية. توقف عن تناول هذه الأدوية قبل استخدام إيميجران بما لا يقل عن ٢٤ ساعة. لا تتناول أي أدوية تحتوي على الإرجوتامين أو مركبات مشابهة للإرجوتامين مرة أخرى قبل مرور ٦ ساعات على الأقل بعد استخدام إيميجران.</p><p><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية التريبتان الأخرى</strong>/منبهات مستقبلات ٥-إتش تي ١ (مثل ناراتريبتان وريزاتريبتان وزولميتريبتان)، التي تستخدم أيضًا لعلاج الصداع النصفي، (انظر الفقرة ٢ لا تستخدم إيميجران). لا تستخدم إيميجران في نفس الوقت الذي تتناول فيه هذه الأدوية. توقف عن تناول هذه الأدوية قبل استخدام إيميجران بما لا يقل عن ٢٤ ساعة. &rlm;‫لا تتناول أي من أدوية التريبتان/منبهات مستقبلات ٥-إتش تي ١ الأخرى مرة أخرى قبل مرور ٢٤ ساعة على الأقل بعد استخدام إيميجران.</p><p><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات أوكسيديز أحادي الأمين</strong> (MAOI) المستخدمة لعلاج الاكتئاب. لا تستخدم إيميجران إذا كنت قد تناولت هذه الأدوية خلال الأسبوعين الماضيين.</p><p><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات امتصاص السيروتونين الانتقائية</strong> (SSRI) أو مثبطات امتصاص السيروتونين النورادرينالين (SNRI) المستخدمة لعلاج الاكتئاب. إن استخدام إيميجران مع هذه الأدوية يمكن أن يسبب متلازمة السيروتونين (مجموعة من الأعراض التي يمكن أن تشمل الأرق والارتباك والتعرق والهلوسة وزيادة المنعكسات وتشنجات العضلات ورعشة وزيادة ضربات القلب وارتجاف). أخبر طبيبك على الفور إذا أصابتك أي من هذه الآثار.</p><p><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نبتة سانت جونز</strong> (العرن المثقوب). إن تناول العلاجات العشبية التي تحتوي على نبتة سانت جونز أثناء استخدام إيميجران قد يزيد من احتمالية حدوث الآثار الجانبية.</p><p>&nbsp;</p><p><strong>&not;</strong><strong> يجب الاتصال بالطبيب على الفور، </strong>إذا أصبت بأي من هذه الأعراض.</p><p><strong>الحمل والرضاعة الطبيعية </strong></p><p><strong>إيميجران لا يوصى بتناوله أثناء الحمل.</strong> إذا كنت <strong>حامل</strong>، أو <strong>تظنين أنك قد تكونين حامل</strong>، أو إذا كنت <strong>تخططين للحمل، لا يجوز تناول إيميجران</strong> دون الرجوع إلى الطبيب. <strong>طبيبك</strong> سيضع بعين الاعتبار المنفعة المتوقعة لك والمخاطر على طفلك الناتجة عن تناول إيميجران أثناء الحمل.</p><p>المكونات في إيميجران قد تفرز في حليب الثدي. <strong>لا ترضعي طفلك طبيعياً لمدة 12 ساعة بعد تناول إيميجران.</strong> إذا أفرزت أي كمية من حليب الثدي خلال هذه الفترة، يجب التخلص من الحليب ولا يجوز إعطاؤه لطفلك.</p><p><strong>قيادة السيارات واستعمال الماكينات</strong></p><p>أعراض الصداع النصفي أو إيميجران قد يجعلانك تشعر بدوخة.</p><p><strong>&not;</strong><strong> لا يجوز قيادة السيارات أو استعمال الماكينات إلا إذا كنت تشعر أنك بصحة جيدة.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يجب تناول <strong>إيميجران</strong> دائماً وفقاً لتعليمات الطبيب. يجب الرجوع إلى الطبيب أو الصيدلي إذا لم تكن متأكداً.</p><p><strong>ما الجرعة التي يجب تناولها</strong></p><p><strong>الجرعة المعتادة</strong> <strong>للكبار سن 18 إلى 65 عاماً </strong>هي قرص واحد إيميجران 50ملجم.</p><p>&nbsp;قد يحتاج بعض المرضى إلى 100 ملجم.</p><p><strong>كيفية تناول&nbsp; أقراص </strong><strong>إيميجران</strong></p><p>قم بابتلاع كامل القرص مع بعض الماء.</p><p><strong>متى يجب تناول إيميجران</strong></p><p><strong>يجب تناول إيميجران بمجرد الشعور بصداع نصفي.</strong> رغم أن إيميجران يجوز تناوله أيضاً في أي وقت بعد بداية الشعور بالصداع.</p><p><strong>لا يجوز تناول إيميجران لمحاولة منع الإصابة بنوبة.</strong></p><p><strong>إذا عاودت الأعراض بالظهور</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكنك تناول قرص ثاني من إيميجران بعد مدة لا تقل عن <strong>ساعتين</strong> من الأول.</p><p><strong>إذا لم يكن للقرص الأول أي تأثير</strong></p><p>لا يجوز تناول قرص ثاني أو أي مستحضر إيميجران آخر لعلاج نفس النوبة. إذا لم يسفر إعطاء إيميجران عن أي تخفيف للحالة:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لاتتناول أكثر من عدد 6 أقراص 50 ملجم أو أكثر من عدد 3 أقراص 100 ملجم (المجموع 300 ملجم) خلال 24 ساعة.</p><p>&nbsp;</p><p><strong>&not;</strong><strong> يجب استشارة الطبيب أو الصيدلي.</strong></p><p><strong>إذا تناولت أكثر مما يجب تناوله من إيميجران</strong></p><p>تناول أكثر مما يجب تناوله من إيميجران قد يجعلك تشعر باعتلال. إذا تناولت إيميجران بجرعة أكثر من الجرعة الموصى بها:</p><p>إذا تناولت أكثر من 300 ملجم في غضون 24 ساعة:</p><p><strong>&not;</strong><strong> يجب الاتصال بالطبيب أو الصيدلي في أسرع وقت ممكن لاستشارته. </strong>إن أمكن، أعرض عليهم عبوة إيميجران.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كشأن كافة الأدوية، إيميجران قد يسبب آثاراً جانبية، إلا أنها لا تصيب كل فرد.</p><p><strong>رد فعل أرجي: ويحدث في حالات نادرة جداً لدى أفراد استعملوا إيميجران. العلامات تتضمن:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي بارز مصحوب بحكة <em>(شرى)</em>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه أو الفم أحياناً <em>(وذمة وعائية)</em> مما يسفر عن صعوبة بالتنفس.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انهيار.</p><p><strong>&not;</strong><strong> يجب الاتصال بالطبيب على الفور</strong> إذا أصبت بأي من هذه الأعراض. <strong>يجب وقف تناول إيميجران.</strong></p><p><strong>آثار جانبية شائعة </strong></p><p>هذه التأثيرات قد تصيب <strong>ما يصل إلى فرد واحد من كل 10 </strong>أفراد<strong>:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة، شعور بالوهن، أو الإصابة بنوبات سخونة.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مؤقت بضغط الدم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بغثيان (غثيان) أو الإصابة بغثيان (قيء)، إلا أن ذلك قد يكون ناتجاً عن الصداع النصفي نفسه.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إرهاق أو نعاس.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق النفس.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام عضلية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أحاسيس غير معتادة كالشعور بتنمل، نخز والشعور بالحر/البرد، ألم، ثقل أو ضغط بأي جزء من الجسم بما في ذلك الصدر والحلق.</p><p><strong>آثار جانبية نادرة جداً</strong></p><p>هذه التأثيرات قد تصيب<strong> ما يصل إلى فرد واحد من كل 10000 </strong>فرد:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم بأسفل الجانب الأيسر للمعدة وإسهال مدمى <em>(التهاب القولون الناتج عن نقص التروية الدموية).</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بشرة شاحبة، مائلة إلى الزرقة و/أو ألم بالأصابع، أصابع القدم، الأذن، الأنف، أو الفك نتيجة التعرض للبرد أو لضغط عصبي <em>(ظاهرة راينود).</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات صرع (نوبات)، ارتعاش، تقلص عضلي، تيبس العنق.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بإغماء (قد ينخفض ضغط الدم).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل قلبية حيث أن ضربات القلب قد تتسارع <em>(تسارع ضربات القلب)</em>، أو تتباطأ <em>(تباطؤ ضربات القلب)</em> أو تغير نظمها <em>(اضطراب نظم القلب).</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة قلبية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رد فعل أرجي.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطربات بالرؤية مثل وميض، ضعف الرؤية، ازدواج الرؤية، فقدان الرؤية، وفي بعض الحالات حتى أضرار دائمة (إلا أنها قد تكون ناتجة عن نوبة الصداع النصفي نفسها).</p><p>آثار جانبية نادرة جداً قد تظهر في اختبارات الدم:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات طفيفة في وظائف الكبد.</p><p><strong>في حالة الإصابة بآثار جانبية</strong></p><p><strong>&not;</strong><strong> يجب إبلاغ الطبيب أو الصيدلي</strong> إذا أصبحت أي من الآثار الجانبية المدرجة بالنشرة <strong>شديدة أو تمثل مشكلة،</strong> أو إذا لاحظت أية آثار جانبية غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يحفظ بعيداً عن متناول ونظر الأطفال.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجوز تناول أقراص إيميجران بعد تاريخ انتهاء الصلاحية المبين على العبوة بعد كلمة &quot;Exp&quot;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم حفظ أقراص إيميجران في درجة حرارة أعلى من 30<sup>&deg;</sup>م.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا نصحك الطبيب بوقف تناول أقراص إيميجران، فمن المهم إعادة أي كمية متبقية إلى الصيدلي.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجوز التخلص من الأدوية في مياه الصرف الصحي أو المخلفات المنـزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد على وقاية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما يحتوي عليه إيميجران </strong></p><p><strong>المادة الفعالة:</strong></p><p>&nbsp;<strong><em>أقراص إيميجران 50</em></strong> تحتوي على 50ملجم من سوماتريـﭙـتان كقاعدة لملح الساكسينات.</p><p><strong><em>أقراص إيميجران 100</em></strong> تحتوي على 100ملجم من سوماتريـﭙـتان كقاعدة لملح الساكسينات.</p><p>المكونات الأخرى الغير فعالة:</p><p><strong><em>أقراص إيميجران 50</em></strong>: لاكتوز (أحادي الهيدرات)، لاكتوز (لامائي)، سيليولوز دقيق التبلور، كروسكارميلوز الصوديوم، ستياريت الماغنيسيوم، ماء مقطر.</p><p><strong><em>أقراص إيميجران 100</em></strong>: لاكتوز (أحادي الهيدرات)، سيليولوز دقيق التبلور، كروسكارميلوز الصوديوم، ستياريت الماغنيسيوم، ماء مقطر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>كيف يبدو إيميجران ومحتويات العبوة أقراص إيميجران 50: أقراص وردية مكسوة بكسوة غشائية، على شكل كبسولة محدبة الوجهين منقوش على أحد وجهيها GX ES3 ومسطحة على الوجه الآخر، أو منقوش 50 على أحد وجهيها ومسطحة على الوجه الآخر. معبأة في جيوب مفردة داخل عبوات فقاعية ذات رقاقة معدنية مزدوجة في علبة كرتونية. أقراص إيميجران 100: أقراص بيضاء إلى ظليلة البياض مكسوة بكسوة غشائية، على شكل كبسولة محدبة الوجهين منقوش على أحد وجهيها GX ET2 ومسطحة على الوجه الآخر، أو منقوش 100 على أحد وجهيها ومسطحة على الوجه الآخر. معبأة في جيوب مفردة داخل عبوات فقاعية ذات رقاقة معدنية مزدوجة في علبة كرتونية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>تصنيع:</strong></p><p>دﻳﻠﻔﺎرم‬ بوزنان أسبولكا أكسيجنا، أولي.&nbsp;ﺟﺮاﻧﭭﺎﻟﺴﻜﺎ‬ 189، 60 - 322&nbsp;بوزنان،&nbsp;ﺑﻮﻟﻨﺪا‬</p><p><strong>تعبئة:</strong></p><p>جلاكسو العربية السعودية المحدودة* جدة، السعودية.</p><p><strong>الشركة المالكة لرخصة التسويق</strong></p><p>جلاكسو العربية السعودية المحدودة*، جدة، السعودية</p><p>العنوان: صندوق بريد22617، جدة 21416، المملكة العربية السعودية.</p><p>* شركة تنتمي إلى مجموعة شركات جلاكسو سميث كلاين.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            إصدار رقم: GDS24
تاريخ الإصدار: 10 أبريل 2023

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                IMIGRAN 
Sumatriptan Tablets

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets containing 50 or 100 mg of sumatriptan base as the succinate salt.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                IMIGRAN tablets 50 mg are pink, film coated, capsule-shaped biconvex tablets (of nominal dimensions 12x 6.5mm) engraved GX ES3 on one face and plain on the other face or 50 on one face and plain on the other face.
IMIGRAN tablets 100mg are white to off-white, film coated, capsule-shaped  biconvex  tablets  (of  nominal   dimensions 12x 6.5mm) engraved GX ET2 on one face and plain on the other face or 100 on one face and plain on the other face.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>IMIGRAN</em> tablets are indicated for the acute relief of migraine attacks with or without aura, including the acute treatment of migraine attacks associated with the menstrual period in women.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>IMIGRAN</em> should not be used prophylactically. The recommended dose of <em>IMIGRAN</em> should not be exceeded.</p><p>It is advisable that sumatriptan be given as early as possible after the onset of a migraine headache.&nbsp; It is equally effective at whatever stage of the attack it is administered.</p><p><strong>Populations</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Adults</strong></p><p>The recommended dose of oral <em>IMIGRAN</em> is a single 50&nbsp;mg tablet. Some patients may require 100&nbsp;mg.</p><p>If a patient does not respond to the first dose of <em>IMIGRAN</em>, a second dose should not be taken for the same attack. <em>IMIGRAN</em> tablets may be taken for subsequent attacks.</p><p>If the patient has responded to the first dose, but the symptoms recur a second dose may be given, provided that there is a minimum interval of two hours between doses and not more than 300&nbsp;mg is taken in any 24-hour period.</p><p>The tablets should be swallowed whole with water.&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Children and Adolescents </strong><strong>(under 18 years of age)</strong></p><p>The efficacy of sumatriptan tablets in this population has not been demonstrated (<em>see</em><em> Clinical Studies</em>).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Elderly</strong><strong> (over 65 years of age)</strong></p><p>Experience of the use of sumatriptan tablets in patients aged over 65 years is limited. The pharmacokinetics do not differ significantly from a younger population, but until further clinical data are available, the use of <em>IMIGRAN</em> in patients aged over 65 years is not recommended.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to any component of the preparation. 
	IMIGRAN should not be given to patients who have had myocardial infarction or have ischaemic heart disease (IHD), Prinzmetal's angina/coronary vasospasm, peripheral vascular disease or patients who have symptoms or signs consistent with IHD.
	IMIGRAN should not be administered to patients with a history of previous cerebrovascular accident (CVA) or transient ischaemic attack (TIA).
	The use of IMIGRAN in patients with uncontrolled hypertension is contraindicated.
	IMIGRAN should not be administered to patients with severe hepatic impairment.
	The concomitant use of ergotamine or derivatives of ergotamine (including methysergide) is contraindicated (see Interactions).
	Concurrent administration of monoamine oxidase inhibitors (MAOIs) and IMIGRAN is contraindicated. IMIGRAN must not be used within two weeks of discontinuation of therapy with MAOIs.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>IMIGRAN</em> should only be used where there is a clear diagnosis of migraine.</p><p><em>IMIGRAN</em> is not indicated for use in the management of hemiplegic, basilar or ophthalmoplegic migraine.</p><p>Before treating with <em>IMIGRAN</em>, care should be taken to exclude potentially serious neurological conditions (e.g. CVA, TIA) if the patient presents with atypical symptoms or if they have not received an appropriate diagnosis for <em>IMIGRAN </em>use.</p><p>Following administration, <em>IMIGRAN</em> can be associated with transient symptoms including chest pain and tightness which may be intense and involve the throat (<em>see Adverse Reactions</em>). Where such symptoms are thought to indicate IHD appropriate evaluation should be carried out.</p><p><em>IMIGRAN</em> should not be given to patients in whom unrecognised cardiac disease is likely without a prior evaluation for underlying cardiovascular disease. Such patients include postmenopausal women, males over 40 and patients with risk factors for coronary artery disease. However, these evaluations may not identify every patient who has cardiac disease and, in very rare cases, serious cardiac events have occurred in patients without underlying cardiovascular disease.</p><p><em>IMIGRAN</em> should be administered with caution to patients with controlled hypertension as transient increases in blood pressure and peripheral vascular resistance have been observed in a small proportion of patients.</p><p>There have been rare post-marketing reports describing patients with serotonin syndrome (including altered mental status, autonomic instability and neuromuscular abnormalities) following the use of a selective serotonin re-uptake inhibitor (SSRI) and sumatriptan. Serotonin syndrome has been reported following concomitant treatment with triptans and serotonin noradrenaline re-uptake inhibitors (SNRIs). &nbsp;</p><p>If concomitant treatment with <em>IMIGRAN</em> and an SSRI/SNRI is clinically warranted, appropriate observation of the patient is advised (<em>see Interactions</em>).</p><p>The concomitant administration of any triptan/5-HT1 agonist with <em>IMIGRAN</em> is not recommended</p><p><em>IMIGRAN</em> should be administered with caution to patients with conditions that may affect significantly the absorption, metabolism or excretion of the drug, e.g. impaired hepatic (Child Pugh grade A or B; <em>see Pharmacokinetics &ndash; Special Patient Populations</em>) or renal function (<em>see Pharmacokinetics</em>).</p><p><em>IMIGRAN</em> should be used with caution in patients with a history of seizures or other risk factors which lower the seizure threshold.</p><p>Patients with known hypersensitivity to sulphonamides may exhibit an allergic reaction following administration of <em>IMIGRAN</em>. Reactions may range from cutaneous hypersensitivity to anaphylaxis. Evidence of cross-sensitivity is limited, however, caution should be exercised before using <em>IMIGRAN</em> in these patients.</p><p>Undesirable effects may be more common during concomitant use of triptans and herbal preparations containing St John&#39;s Wort (Hypericum perforatum).</p><p>Overuse of acute headache treatments has been associated with the exacerbation of headache (medication overuse headache, MOH) in susceptible patients.&nbsp; Withdrawal of the treatment may be necessary</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no evidence of interactions with propanolol, flunarizine, pizotifen or alcohol.</p><p>Prolonged vasospastic reactions have been reported with ergotamine. As these effects may be additive, 24 hours should elapse before sumatriptan can be taken following any ergotamine containing preparation. Conversely, ergotamine containing preparations should not be taken until six hours have elapsed following <em>IMIGRAN</em> administration.</p><p>An interaction may occur between <em>IMIGRAN</em> and MAOIs and concomitant administration is contraindicated (<em>see Contraindications</em>).</p><p>There have been rare post-marketing reports describing patients with serotonin syndrome (including altered mental status, autonomic instability and neuromuscular abnormalities) following the use of SSRIs and sumatriptan. Serotonin syndrome has also been reported following concomitant treatment with triptans and SNRIs<strong><em> </em></strong>(<em>see Warnings and Precautions</em>).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>Caution should be exercised by considering the expected benefit to the mother against possible risk to the foetus.</p><p>Post-marketing data from multiple prospective pregnancy registries have documented the pregnancy outcomes in over 1,000 women exposed to sumatriptan. Although there is insufficient information to draw definitive conclusions, the findings have not detected an increase in the frequency of birth defects nor a consistent pattern of birth defects, amongst women exposed to sumatriptan compared with the general population.</p><p>Lactation</p><p>It has been demonstrated that following subcutaneous administration, sumatriptan is excreted into breast milk. Infant exposure can be minimised by avoiding breast-feeding for 12 hours after treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Drowsiness may occur as a result of migraine or treatment with sumatriptan.</p><p>Caution is recommended in patients performing skilled tasks, e.g. driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse events are listed below by system organ class and frequency.&nbsp; Frequencies are defined as: very common (&sup3;1/10), common (&sup3;1/100 to &lt;1/10), uncommon (&sup3;1/1000 to &lt;1/100), rare (&sup3;1/10000 to &lt;1/1000) and very rare (&lt;1/10000) including isolated reports. The data from clinical trials are estimates. It should be noted that the background rate in comparator groups was not taken into account. Post-marketing data refer to reporting rate rather than true frequency.</p><p>Clinical Trial Data</p><p><strong>Nervous System Disorders</strong></p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness, drowsiness,sensory disturbance including paraesthesia and hypoaesthesia.</p><p><strong>Vascular disorders</strong></p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transient increases in blood pressure arising soon after treatment.&nbsp; Flushing.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>&nbsp;Dyspnoea.</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>Gastrointestinal Disorders</strong></p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea and vomiting occurred in some patients but the relationship to sumatriptan is not clear.</p><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p><p>The following symptom is usually transient and may be intense and can affect any part of the body including the chest and throat:</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sensations of heaviness.</p><p><strong>General Disorders and Administration Site Conditions</strong></p><p>The following symptoms are usually transient and may be intense and can affect any part of the body including the chest and throat:</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain, sensations of heat or cold, pressure or tightness.</p><p>The following symptoms are mostly mild to moderate in intensity and transient:</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feelings of weakness, fatigue.</p><p><strong>Investigations</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Minor disturbances in liver function tests have occasionally been observed.</p><p>&nbsp;</p><p>Post-Marketing Data</p><p><strong>Immune System Disorders</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity reactions ranging from cutaneous hypersensitivity to anaphylaxis.</p><p><strong>Nervous System Disorders</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seizures, although some have occurred in patients with either a history of seizures or concurrent conditions predisposing to seizures there are also reports in patients where no such predisposing factors are apparent.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor, dystonia, nystagmus, scotoma.</p><p><strong>Eye disorders</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flickering, diplopia, reduced vision. &nbsp;&nbsp;&nbsp; Loss of vision (usually transient). However, visual disorders may also occur during a migraine attack itself.</p><p><strong>Cardiac disorders</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bradycardia, tachycardia, palpitations, cardiac arrhythmias, transient ischaemic ECG changes, coronary artery vasospasm, angina, myocardial infarction (<em>see Contraindications, Warnings and Precautions</em>).</p><p><strong>Vascular disorders</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypotension, Raynaud&rsquo;s phenomenon.</p><p><strong>Gastrointestinal Disorders</strong></p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ischaemic colitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms and Signs</p><p>Doses in excess of 400&nbsp;mg orally were not associated with side effects other than those mentioned.</p><p>Treatment</p><p>If overdosage occurs, the patient should be monitored for at least 10 hours and standard supportive treatment applied as required.</p><p>It is unknown what effect haemodialysis or peritoneal dialysis has on the plasma concentrations of sumatriptan.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC Code</p><p>N02CC01.</p><p>Mechanism of Action</p><p>Pharmacotherapeutic group: Selective 5-HT<sub>1 </sub>receptor agonists.</p><p>Sumatriptan has been demonstrated to be a selective vascular 5-hydroxytryptamine-1-(5-HT<sub>1</sub>D) receptor agonist with no effect at other 5-HT receptor (5-HT<sub>2&ndash;7</sub>) subtypes. The vascular 5-HT<sub>1</sub>D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction.</p><p>In animals, sumatriptan selectively constricts the carotid arterial circulation, but does not alter cerebral blood flow. The carotid arterial circulation supplies blood to the extracranial and intracranial tissues such as the meninges and dilatation and/or oedema formation in these vessels is thought to be the underlying mechanism of migraine in man. In addition, experimental evidence suggests that sumatriptan inhibits trigeminal nerve activity. Both these actions may contribute to the anti-migraine action of sumatriptan in humans.</p><p>Pharmacodynamic Effects</p><p>Clinical response begins 10 to 15 minutes following a 6&nbsp;mg subcutaneous injection, 15&nbsp;minutes following a 20&nbsp;mg dose given by intra-nasal administration and around 30&nbsp;minutes following a 100&nbsp;mg oral dose or 25&nbsp;mg rectal dose.</p><p>Although the recommended dose of oral <em>IMIGRAN</em> is 50&nbsp;mg, migraine attacks vary in severity both within and between patients. Doses of 25 to 100&nbsp;mg have shown greater efficacy than placebo in clinical trials, but 25&nbsp;mg is statistically significantly less effective than 50 and 100&nbsp;mg</p><p><em>IMIGRAN</em> is effective in the acute treatment of migraine including menstrually-associated migraine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetics of sumatriptan do not appear to be significantly affected by migraine attacks.</p><p>Absorption</p><p>After oral administration, sumatriptan is rapidly absorbed, 70% of maximum concentration occurring at 45 minutes. After a 100&nbsp;mg dose the mean maximum plasma concentration is 54&nbsp;nanograms/mL.</p><p>Mean absolute oral bioavailability is 14% partly due to pre-systemic metabolism and partly due to incomplete absorption.</p><p>Distribution</p><p>Plasma protein binding is low (14 to 21%); the mean total volume of distribution is 170&nbsp;litres.</p><p>Metabolism</p><p>The major metabolite, the indole acetic acid analogue of sumatriptan is mainly excreted in urine, where it is present as a free acid and the glucuronide conjugate. It has no known 5-HT<sub>1</sub> or 5-HT<sub>2</sub> activity. Minor metabolites have not been identified.</p><p>Elimination</p><p>The elimination half-life is approximately two hours. The mean total plasma clearance is approximately 1,160&nbsp;mL/min and the mean renal plasma clearance is approximately 260&nbsp;mL/min.</p><p>Non-renal clearance accounts for about 80% of the total clearance. Sumatriptan is eliminated primarily by oxidative metabolism mediated by monoamine oxidase A.</p><p>Special Patient Populations</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Hepatic impairment</strong></p><p>Following oral administration, pre-systemic clearance is reduced in patients with hepatic impairment resulting in increased plasma levels of sumatriptan (<em>see Warnings and Precautions</em>).</p><p><strong>Clinical Studies</strong></p><p>A number of placebo-controlled clinical studies assessed the safety and efficacy of oral sumatriptan standard tablets in over 650 child and adolescent migraineurs aged 10 to 17 years. These studies failed to demonstrate a statistically significant difference in headache relief at two hours between placebo and any sumatriptan dose. The undesirable effects profile of oral sumatriptan in children and adolescents aged 10 to17 years was similar to that reported from studies in the adult population</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carcinogenesis, mutagenesis</p><p>Sumatriptan was devoid of genotoxic and carcinogenic activity in <em>in-vitro</em> systems and animal studies.</p><p>Reproductive toxicology</p><p>In a rat fertility study, oral doses of sumatriptan resulting in plasma levels approximately 200 times those seen in man after a 100&nbsp;mg oral dose were associated with a reduction in the success of insemination.</p><p>This effect did not occur during a subcutaneous study where maximum plasma levels achieved approximately 150 times those in man by the oral route.</p><p>Pregnancy and lactation</p><p>No teratogenic effects have been seen in rats or rabbits, and sumatriptan had no effect on the post-natal development of rats.</p><p>When administered to pregnant rabbits throughout the period of organogenesis sumatriptan has occasionally caused embryolethality at doses that were sufficiently high to produce maternal toxicity</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>List of Excipients</p><p><strong>50 mg</strong></p><p>Lactose (monhydrate)</p><p>Lactose (anhydrous)</p><p>Microcrystalline cellulose</p><p>Croscarmellose sodium</p><p>Magnesium stearate</p><p>Purified water</p><p>&nbsp;</p><p><strong>100 mg</strong></p><p>Lactose (monhydrate)</p><p>Microcrystalline cellulose</p><p>Croscarmellose sodium</p><p>Magnesium stearate</p><p>Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store <em>IMIGRAN </em>tablets above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>IMIGRAN</em> tablets 50&nbsp;mg are packed in individual pockets in cold form foil/child-resistant lidding foil blister packs and placed in a cardboard carton.</p><p><em>IMIGRAN</em> tablets 100&nbsp;mg are packed in individual pockets in cold form foil/child-resistant lidding foil blister packs and placed in a cardboard carton.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufactured by:
Delpharm Poznań Spółka Akcyjna, ul. Grunwaldzka 189, 60-322 Poznan, Poland
Packed by:
Glaxo Saudi Arabia Ltd.*, Jeddah, KSA.
Marketing Authorisation Holder 
Glaxo Saudi Arabia Ltd.* Jeddah, KSA.
Address: P.O. Box 22617 Jeddah 21416 – Kingdom of Saudi Arabia.
*member of GlaxoSmithKline group of companies.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: GDS 24 / IPI 08
Date of issue:  22 April 2015

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>